help us beat brain cancer

Ependymoma is the third most common pediatric central nervous system (CNS) tumor, accounting for 8-10% of all diagnoses, and occurring most frequently in the posterior fossa. Unfortunately, outcomes for ependymomas are suboptimal - overall survival is 50-64%.

The treatments for ependymoma have not changed in any significant way for decades, which is why we need a new approach.

Please help us support new research to save the lives of children diagnosed with this challenging disease.

Thank you for helping us hit our 2024 goal!

2025 Fundraising Campaign

Please check if your employer matches donations!